Search Results

Filter
  • 1-10 of  72 results for ""GLUCAGON-like peptide-1 receptor""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor.

  • Authors : Johnson RM; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, Victoria, Australia; ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, Victoria, Australia.

Subjects: Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*chemistry ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism ; Peptides/Peptides/Peptides/*chemistry

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2021 Nov 12; Vol. 578, pp. 84-90. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Specific interaction of insulin receptor and GLP-1 receptor mediates crosstalk between their signaling.

  • Authors : Wang Y; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Song X

Subjects: Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/metabolism ; Insulin-Secreting Cells*/Insulin-Secreting Cells*/Insulin-Secreting Cells*/metabolism; Receptors, Glucagon

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2022 Dec 25; Vol. 636 (Pt 2), pp. 31-39. Date of Electronic Publication:Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Inhibitory effects of glucagon-like peptide-1 receptor on epilepsy.

  • Authors : Wen Y; Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Number 1, Youyi Road Yuzhong District, 400042, Chongqing, China.; Wu K

Subjects: Epilepsy/Epilepsy/Epilepsy/*drug therapy ; Epilepsy/Epilepsy/Epilepsy/*pathology ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2019 Mar 26; Vol. 511 (1), pp. 79-86. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic β-cells.

  • Authors : Sho H; Departments of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita, Japan.; Fukui K

Subjects: Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism ; Glucose Transporter Type 2/Glucose Transporter Type 2/Glucose Transporter Type 2/*metabolism ; Hyperinsulinism/Hyperinsulinism/Hyperinsulinism/*etiology

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2021 Jan 01; Vol. 534, pp. 702-706. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Synthetic protease-activated class B GPCRs.

  • Authors : Willard FS; Quantitative Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: .; Meredith TD

Subjects: Exenatide/Exenatide/Exenatide/*metabolism ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*metabolism ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Sep 10; Vol. 530 (1), pp. 246-251. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases.

  • Authors : Nohara H; Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Chuo-ku, Kumamoto, 862-0973, Japan; Program for Leading Graduate Schools 'HIGO (Health Life Science: Interdisciplinary and Glocal Oriented) Program', Kumamoto University, 5-1 Oe-Honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.

Subjects: Exenatide/Exenatide/Exenatide/*therapeutic use ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Apr 02; Vol. 524 (2), pp. 332-339. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.

  • Authors : Zhou M; Pathophysiology Department, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.; Chen S

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*analogs & derivatives

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2019 Mar 26; Vol. 511 (1), pp. 154-160. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evidence for glucagon-like peptide-1 receptor signaling to activate ATP-sensitive potassium channels in pancreatic beta cells.

  • Authors : Kwon HJ; Department of Physiology & Obesity-mediated Disease Research Center, Keimyung University School of Medicine, 1095 Dalgubeoldae-Ro, Dalseo-Gu, Daegu 42601, South Korea.; Park HS

Subjects: Calcium/Calcium/Calcium/*metabolism ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism ; Insulin-Secreting Cells/Insulin-Secreting Cells/Insulin-Secreting Cells/*physiology

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2016 Jan 08; Vol. 469 (2), pp. 216-21. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.

  • Authors : Mi B; Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China; Department of Nuclear Medicine, Affiliated Hospital of Jiangnan University (Wuxi 4th People's Hospital), Wuxi, Jiangsu, 214062, China.

Subjects: Diabetes Mellitus/Diabetes Mellitus/Diabetes Mellitus/*metabolism ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism ; Molecular Imaging/Molecular Imaging/Molecular Imaging/*methods

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2016 Feb 26; Vol. 471 (1), pp. 47-51. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.

  • Authors : Gómez Santiago C; School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK. Electronic address: .; Paci E

Subjects: Molecular Dynamics Simulation*; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*chemistry

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2018 Mar 29; Vol. 498 (2), pp. 359-365. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  72 results for ""GLUCAGON-like peptide-1 receptor""